Trial Profile
Insulin degludec compared with conventional basal insulin in basal-bolus therapy with type 1 and type2 diabetes in outpatient: A 24-week, randomized, open-label, treat-to-target trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 May 2016
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 28 May 2016 New trial record